TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 79 of 161 • 4,024 articles
AVTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
AVTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 09:10 AM • Faruqi & Faruqi is investigating potential securities claims against Avantor, alleging the company misled investors about its competitive positioning and market performance between March 2024 and October 2025.

TGT - Mentioned as one of the major employers conducting job cuts in 2025
AVTR - The company experienced significant stock price declines, reduced financial guidance, leadership changes, reported losses, and admitted to competitive pressures negatively impacting business performance
#securities litigation #class action #investor losses #competitive positioning
Read More
Better U.S. Treasury ETF: Schwab Long-Term U.S. Treasury vs. Vanguard Long-Term Treasury
The Motley Fool • Robert Izquierdo
Better U.S. Treasury ETF: Schwab Long-Term U.S. Treasury vs. Vanguard Long-Term Treasury

11/09/2025 09:05 AM • The article compares two long-term U.S. Treasury ETFs from Schwab and Vanguard, analyzing their expense ratios, performance, dividend yields, and overall investment potential for government bond investors.

META - Mentioned as one of the major employers conducting job cuts in 2025
SCHQ - Offers competitive expense ratio, comparable returns, strong performance, and cost-effectiveness with 95 holdings focused on long-term U.S. Treasury bonds
#ETF #Treasury bonds #long-term investment #government securities #dividend yield
Read More
NJDCY SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec
GlobeNewswire Inc. • James (Josh) Wilson
NJDCY SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

11/09/2025 09:04 AM • Nidec Corporation is under investigation for suspected improper accounting practices, leading to significant stock price declines and a Tokyo Stock Exchange special security alert.

SBUX - Mentioned as one of the major employers conducting job cuts in 2025
NJDCY - Multiple investigations revealed potential accounting misconduct, stock price dropped substantially (over 68% across several disclosures), and Tokyo Stock Exchange issued a special security alert due to identified internal control deficiencies
#accounting irregularities #stock investigation #internal controls
Read More
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
GlobeNewswire Inc. • Marat Fudim, Md, Mhs
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

11/09/2025 09:00 AM • Medera Inc. announced positive interim data from its MUSIC-HFpEF Phase 1/2a clinical trial for a gene therapy treatment targeting heart failure with preserved ejection fraction (HFpEF), demonstrating a favorable safety profile and early clinical benefits in treated patients.

JPMpC - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
AZN - Mentioned as a collaborator in developing HFpEF disease model, with no specific performance details provided
#gene therapy #heart failure #clinical trial #SERCA2a #cardiovascular disease
Read More
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
GlobeNewswire Inc. • Monopar Therapeutics Inc.
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

11/09/2025 09:00 AM • Monopar Therapeutics presented new data at AASLD showing that ALXN1840 (tiomolybdate choline) rapidly improved copper balance in Wilson disease patients through increased fecal copper excretion.

JPM - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
MNPR - Presented promising clinical study results demonstrating potential effectiveness of their drug ALXN1840 in treating Wilson disease, indicating positive research progress
#Wilson disease #copper balance #tiomolybdate choline #clinical study #liver disease
Read More
WPP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that WPP Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
WPP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that WPP Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:57 AM • Faruqi & Faruqi is investigating potential securities law violations by WPP, alleging false statements about revenue expectations and market performance during the first half of 2025, which led to a significant stock price decline.

JPMpD - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
WPP - The company experienced an 18.1% stock price drop after revealing performance deterioration, alleged misleading statements about market performance, and challenges in its media division amid macroeconomic uncertainties
#securities litigation #class action #stock decline #revenue expectations #investor losses
Read More
NX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Quanex Building Products Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
NX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Quanex Building Products Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:56 AM • Quanex Building Products faces potential securities lawsuit over alleged misleading statements regarding operational issues in its Mexico facility, with stock price declining after disclosing significant financial and operational challenges.

JPMpJ - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
NX - Company disclosed significant operational challenges in Mexico facility, reported substantial financial losses (EPS of -$6.04), acknowledged underinvestment in equipment maintenance, and experienced stock price decline of over 23% in two trading days
#securities lawsuit #class action #financial disclosure #operational issues #Tyman integration
Read More
MOH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Molina Healthcare Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
MOH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Molina Healthcare Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:52 AM • Molina Healthcare faces potential securities class action lawsuit after reducing financial guidance twice in July 2025, citing medical cost pressures and challenging market conditions.

JPMpK - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
MOH - Company significantly reduced full-year earnings guidance twice within two weeks, from $24.50 to $19.00 per share, attributed to medical cost pressures and decreased performance across business lines
#securities litigation #medical cost trend #earnings guidance #class action
Read More
LNTH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc. • Faruqi & Faruqi, Llp
LNTH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 08:50 AM • Faruqi & Faruqi is investigating potential claims against Lantheus Holdings regarding misleading statements about Pylarify's competitive position, with stock price dropping 28.8% after disappointing Q1 and fiscal year results.

JPMpL - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
LNTH - Stock price declined 28.8% after reporting below-market Q1 results, reduced growth expectations for Pylarify, and acknowledging competitive challenges impacting pricing dynamics
#securities litigation #class action #shareholder lawsuit #stock decline
Read More
LRN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride
GlobeNewswire Inc. • James (Josh) Wilson
LRN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride

11/09/2025 08:47 AM • Faruqi & Faruqi is investigating potential claims against Stride Inc. after the company experienced significant stock price drops following allegations of fraud and enrollment challenges.

JPMpM - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
LRN - Stock price dropped 11.7% after fraud allegations and another 51% after revealing enrollment and system implementation issues, indicating significant investor concerns about company performance and potential legal challenges
#securities litigation #enrollment fraud #stock price decline
Read More
Meet the Newest Addition to the S&P 500. The Stock Has Soared 200% Since Early Last Year, and Is Still a Buy Right Now, According to 1 Wall Street Analyst.
The Motley Fool • Neha Chamaria
Meet the Newest Addition to the S&P 500. The Stock Has Soared 200% Since Early Last Year, and Is Still a Buy Right Now, According to 1 Wall Street Analyst.

11/09/2025 08:20 AM • Emcor Group, a specialty infrastructure services contractor, recently joined the S&P 500 index and has seen remarkable stock growth of 200% since early 2024, driven by strong demand in AI data centers and infrastructure projects.

PLTR - Tumbled 7.51% despite strong earnings, with Michael Burry's fund purchasing significant put options
EME - Stock has soared 200% since early 2024, has record revenue and RPOs, strong growth in AI and data center markets, projected 15% revenue growth in 2025, and received a buy rating from Wall Street analyst with a potential 23% upside
#S&P 500 #AI #data centers #infrastructure #specialty contractor
Read More
As Warren Buffett Prepares to Step Down, His Warning to Wall Street Is Now at Ear-Shattering Levels
The Motley Fool • Bram Berkowitz
As Warren Buffett Prepares to Step Down, His Warning to Wall Street Is Now at Ear-Shattering Levels

11/09/2025 08:20 AM • Warren Buffett is stepping down as CEO of Berkshire Hathaway at year-end, with the company showing cautious market sentiment by accumulating cash and selling stocks, indicating potential market overvaluation.

DENN - Surged 49.15% after announcing definitive agreement to be acquired for approximately $620 million
BRK.A - Maintaining large cash reserves, being selective about investments, and showing caution about current market valuations
#Warren Buffett #market valuation #cash reserves #stock market #investment strategy
Read More
Bitcoin's
The Motley Fool • Leo Sun
Bitcoin's "Uptober" Was a Bust for 2025. Here's What That Means for the Leading Crytocurrency.

11/09/2025 08:15 AM • Bitcoin experienced its first negative October since 2018, dropping 5% despite previous strong performance. The decline was attributed to elevated Treasury yields, profit-taking, and reduced investor support, though long-term prospects remain promising.

TCPC - Mentioned as one of the institutional investors supporting Bitcoin's broader adoption
#Bitcoin #cryptocurrency #halving #ETF #Federal Reserve #interest rates
Read More
Got About $45? This Is a Great Dividend Stock to Buy Right Now.
The Motley Fool • Matt Dilallo
Got About $45? This Is a Great Dividend Stock to Buy Right Now.

11/09/2025 08:09 AM • Brookfield Renewable offers a high-yielding dividend stock with potential for significant growth, driven by renewable energy investments, long-term contracts, and expansion in sustainable energy solutions.

BEPC - High dividend yield of 3.4%, stable cash flow, projected 5-9% annual dividend growth, and strong growth potential through long-term contracts, margin enhancements, and renewable energy development
#dividend #renewable energy #investment #sustainable solutions #energy infrastructure
Read More
Prediction: XRP (Ripple) Will Surge Past This Price by 2029
The Motley Fool • Adam Levy
Prediction: XRP (Ripple) Will Surge Past This Price by 2029

11/09/2025 08:05 AM • The article predicts XRP could reach over $10 by 2029, driven by positive regulatory developments, resolution of SEC lawsuit, and growing institutional interest in blockchain technology for cross-border transactions.

SAN - Mentioned as testing RippleNet, indicating potential interest in blockchain technology
#XRP #Ripple #cryptocurrency #blockchain #SEC #ETF #cross-border transactions
Read More
What Roblox Could Look Like in 5 Years
The Motley Fool • Lawrence Nga
What Roblox Could Look Like in 5 Years

11/09/2025 07:27 AM • Roblox is poised for potential transformation by 2030, with three key trends: immersive advertising, an aging user base, and international expansion potentially reshaping its business model from a gaming platform to a diverse digital economy.

ARKQ - Actively managed by Cathie Wood, focuses on innovative robotics and automation technologies with unique stock selections
RBLX - The article suggests multiple growth opportunities including ad revenue potential, expanding user demographics, and international market expansion, which could lead to higher margins and more sustainable revenue
#Roblox #metaverse #digital platform #advertising #user demographics #international growth
Read More
1 Reason Nvidia Is the Smartest AI Stock to Buy With $100 Right Now
The Motley Fool • Ryan Vanzo
1 Reason Nvidia Is the Smartest AI Stock to Buy With $100 Right Now

11/09/2025 07:15 AM • Nvidia is recommended as a core AI investment, offering investors insight into the AI landscape by providing exposure to the largest GPU supplier for artificial intelligence applications.

NVDA - Top holding in Global X ETF, provides critical AI chips for robotics applications
NVDA - The article portrays Nvidia as a critical player in AI technology, highlighting its market leadership, GPU dominance, and potential for investor education about the AI industry
#AI #GPU #technology investment #data centers #chip manufacturing
Read More
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio?
Benzinga • Nabaparna Bhattacharya
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio?

11/09/2025 07:08 AM • Multiple large-cap companies reported strong Q3 earnings and raised fiscal year guidance, leading to significant stock price gains across various sectors including technology, travel, and healthcare.

TSLA - Top holding in Ark ETF, has significant robotics ambitions
GMED - Gained 39.79% after better-than-expected Q3 results and raised fiscal year 2025 guidance
#earnings #stock performance #Q3 results #guidance #large-cap stocks
Read More
KMX CLASS REMINDER: CarMax, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by January 2 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
KMX CLASS REMINDER: CarMax, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by January 2 Legal Deadline

11/09/2025 07:07 AM • CarMax faces a securities fraud class action lawsuit after reporting disappointing financial results, including sales declines and an unexpected CEO departure, which triggered a significant stock price drop.

KMX - Stock price dropped 20% after Q2 financial results, experienced sales declines across retail and wholesale units, and faced unexpected CEO departure, indicating significant business challenges
#securities fraud #stock drop #financial performance #class action lawsuit
Read More
JAMF INVESTIGATION REMINDER: The Jamf Holding Corp. Board May have Breached its Fiduciary Duties – Shareholders Urged to Contact BFA Law
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
JAMF INVESTIGATION REMINDER: The Jamf Holding Corp. Board May have Breached its Fiduciary Duties – Shareholders Urged to Contact BFA Law

11/09/2025 07:07 AM • Law firm investigating potential breach of fiduciary duties by Jamf Holding Corp.'s board regarding a take-private sale by Francisco Partners Management at $13.05 per share, with concerns about Vista Equity Partners' significant influence.

JAMF - Potential board misconduct, potential undervaluation of stock, conflict of interest concerns with Vista Equity Partners' significant ownership and board representation
#securities investigation #take-private sale #fiduciary duties #shareholder rights
Read More
JHX CLASS REMINDER: James Hardie Industries plc Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 23 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
JHX CLASS REMINDER: James Hardie Industries plc Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 23 Legal Deadline

11/09/2025 07:07 AM • A class action lawsuit alleges James Hardie Industries misrepresented its North American fiber cement sales performance, with stock dropping 34% after revealing significant inventory destocking and declining sales.

JHX - Company accused of fraudulent channel stuffing, misrepresenting sales performance, and experiencing significant stock price decline after revealing true sales conditions
#securities fraud #class action #stock decline #inventory manipulation
Read More
SNPS CLASS REMINDER: Synopsys, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 30 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
SNPS CLASS REMINDER: Synopsys, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 30 Legal Deadline

11/09/2025 07:07 AM • A class action lawsuit alleges Synopsys misled investors about its Design IP business performance, resulting in a significant stock price drop after revealing challenges with customer customization and business model issues.

SNPS - Stock dropped 36% after revealing underperformance in Design IP segment, declining revenue, increased customer customization challenges, and potential business model disruption
#securities fraud #class action #stock decline #design automation #IP components
Read More
DXCM CLASS REMINDER: DexCom, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 26 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
DXCM CLASS REMINDER: DexCom, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 26 Legal Deadline

11/09/2025 07:07 AM • DexCom faces a class action lawsuit alleging unauthorized design changes to glucose monitoring devices that reduced accuracy and potentially endangered patient health, resulting in significant stock declines after FDA warnings and investigative reports.

DXCM - Multiple stock declines due to FDA warning letters, unauthorized device modifications, potential safety risks, and allegations of prioritizing margins over patient safety
#securities fraud #FDA warning #glucose monitoring #stock decline #medical device
Read More
BYND INVESTIGATION REMINDER: Beyond Meat, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
BYND INVESTIGATION REMINDER: Beyond Meat, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law

11/09/2025 07:07 AM • Beyond Meat is under investigation for potential securities fraud related to asset valuation, with stock price dropping after announcing a material non-cash impairment charge for long-lived assets.

BYND - Stock experienced significant price decline (23%), announced material impairment charges, delayed earnings report, and is under investigation for potential securities law violations
#securities fraud #asset impairment #stock drop #financial investigation
Read More
MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 15 Legal Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 15 Legal Deadline

11/09/2025 07:07 AM • MoonLake Immunotherapeutics faces a securities fraud lawsuit after reporting disappointing Phase 3 VELA trial results for its investigational drug sonelokimab, causing its stock price to drop nearly 90%.

MLTX - Stock price collapsed by 90% after failed clinical trials, potential regulatory approval challenges, and allegations of misleading investors about drug's clinical benefits
#securities fraud #biotechnology #clinical trials #hidradenitis suppurativa #nanobody
Read More